Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 14.3.2024Menarini International Operations Luxembourg S.A. (MNR)36609Oltar 4 mg (tbl 30x4 mg (blis.PVC/PVDC/Al))14.3.2023O
 14.3.2024Pfizer Europe MA EEIG (PFI-BE-3)53239ARTHROTEC FORTE (tbl flm 30x75 mg/200 µg (blis.PA/Al/PVC))14.3.2024O
 14.3.2024Neuraxpharm Bohemia s.r.o. (NUA)6760CArkvimma 100 mg filmom obalené tablety (tbl flm 56x100 mg (blis.PVC/PVDC/Al))14.3.2024O
 14.3.2024Les Laboratoires Servier (SVE-2)55407MUSTOPHORAN (plv fol 1x208 mg+1x4 ml solv. (liek.inj.hnedá+amp.skl.))1.6.2025Z
 14.3.2024STALLERGENES (SLG-1)85040Oralair 300 IR (tbl slg 3x30x300 IR (blis. PA/Al/PVC/Al))14.3.2024R
 14.3.2024B.Braun Melsungen AG (BME)21435Remifentanil B. Braun 2 mg (plc ifu 5x2 mg (liek.inj.skl.))15.4.2024R
 13.3.2024Covis Pharma Europe B.V. (CVP)3426BBrimica Genuair 340 mikrogramov /12 mikrogramov inhalačný prášok (plv inh 1x60 dávok (inh.plast./nehrdz.oceľ))14.3.2024O
 13.3.2024BAUSCH HEALTH IRELAND LIMITED (BAU-3)2846ERalbior 2,5 mg/2,5 mg (cps dur 30x2,5 mg/2,5 mg (blis.BOPA/Al/PVC laminát/Al))14.3.2024U
 13.3.2024Merck Sharp & Dohme B.V. (MSD-NL)52208Janumet 50 mg/850 mg filmom obalené tablety (tbl flm 56x50 mg/850 mg (blis.PVC/PE/PVDC/Al))12.3.2024O
 13.3.2024Merck Sharp & Dohme B.V. (MSD-NL)52215Janumet 50 mg/1000 mg filmom obalené tablety (tbl flm 56x50 mg/1000 mg (blis.PVC/PE/PVDC/Al))12.3.2024O
 13.3.2024TS Pharma s.r.o. (TPH-1)41784MeniSerc 24 (tbl 50x24 mg (blis.PVC/PVDC/Al))14.3.2024R
 13.3.2024Pfizer Europe MA EEIG (PFI-BE-3)40536DEPO-MEDROL 40 mg/ml (sus inj 1x5 ml/200 mg (liek.inj.skl.))9.4.2024R
 13.3.2024G.L. Pharma GmbH (GLH-2)5151COxycomp 20 mg/10 mg tablety s predĺženým uvoľňovaním (tbl plg 60x20 mg/10 mg (blis.PVC/PVDC/Al-bezpeč.bal.))11.3.2024O
 13.3.2024G.L. Pharma GmbH (GLH-2)8712DAbiraterone G.L. Pharma 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.PVC/PVDC/Al))4.3.2024O
 13.3.2024B.Braun Melsungen AG (BME)26932Aqua pro injectione Braun (lif par 20x10 ml (amp.PE))13.3.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)